Myeloid Leukemia

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

Frequency and Risk Factors of Acute Myeloid Leukemia

Study of IMC-EB10 in Participant With Leukemia

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents